Analytical Laboratory Services To Reach USD 333.8 Million By 2021 : Market Growing Expenditure On Drugs And Medical Devices

 What This Report Will Provide?

The key trends for increase in market, by public health organization are the growing expenditure on drugs and medical devices by public health organizations, steps by the government to build up strong analytical testing abilities, increasing number of drug approvals and clinical trials, and rising demand for specialized analytical testing services. However, complex and innovative pharmaceutical products requiring a distinctive analytical testing approach is the major challenge hampering the growth of government support.

Expected Revenue Growth:

[68 Pages Report] The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period.

Major Growth Boosters:

The overall market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services.However, complex and innovative pharmaceutical products requiring a distinctive analytical testing approach is the major challenge hampering the growth of government support on analytical laboratory services.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65590498 

Target Audience

• Government Agencies
• Nonprofit Organizations
• Analytical Laboratories
• Private Analytical Testing Providers

On the basis of type of service, the spend assessment is segmented into eight segments, namely, bioanalytical testing, batch release testing, stability testing, raw material testing, physical characterization, method validation, microbial testing, and environmental monitoring. In 2015, the bioanalytical testing segment accounted for the largest share of the analytical laboratory services market, by public health organization. T

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=65590498 

Increasing number of CROs providing HCS services

HCS is used in several stages of the drug discovery process, including primary and secondary screening, target identification and validation and toxicity studies. As HCS instruments are expensive, they add to the overall drug development expense for pharmaceutical and biopharmaceutical companies. Moreover, budgetary restrictions among academic institutes restrict the purchase of these instruments.

Regional Growth Analysis:

Geographically, the market, by public health organization is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America commanded the largest share, followed by Europe, Asia-Pacific, and the RoW. The major share of this region can be attributed to the high expenditure on quality testing, strong regulatory scenario, increasing number of clinical trials, and the well-established federal testing laboratories in the region. Moreover, Asia-Pacific is expected to grow at the highest CAGR during the forecast period.

Non Invasive Prenatal Testing (NIPT) Market Worth USD 7.3 Billion : Key Industry Insights, Current And Future Perspectives

 Major Growth Boosters:

Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.

Expected Revenue Growth:

[144 Pages Report] The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.

What This Report Will Provide?

The study involved four major activities in estimating the current size of the global non-invasive prenatal testing market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690  

Recent Developments :

• In June 2019, BGI and Eluthia (Germany) launched the NIFTY test (non-invasive prenatal test), under the brand name PreviaTest in Germany.
• In January 2019, Illumina expanded its NIPT platform with the launch of VeriSeq NIPT Solution v2.
• In November 2018, Illumina and Pacific Biosciences signed an agreement for Illumina to acquire Pacific Biosciences. This acquisition will allow Illumina to strengthen its sequencing solutions platform with accurate long-read sequencing capabilities.
• In January 2017, Agilent Technology acquired Multiplicom N.V. (Belgium) in order to create comprehensive offerings for next-generation sequencing solutions. Multiplicom develops and commercializes molecular diagnostic solutions which are useful in the identification of congenital defects early in pregnancy and other genetic diseases

Key Questions Addressed by the Report :

• Where will all these developments take the industry in the mid to long-term?
• What types of annual and multi-year partnerships are NIPT product and service companies exploring?
• Which are the key players in the market and how intense is the competition?
• Which are the recent contracts and agreements key players have signed?
• What are the recent trends affecting NIPT product and service providers?

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=145607690  

The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period

By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests. The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to technological advancements and increasing company initiatives to develop new products.

Regional Growth Analysis:

Geographically, the non-invasive prenatal testing market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2019, North America accounted for the largest market share, followed by Europe. On the other hand, Asia is expected to grow at the highest CAGR during the forecast period. The developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in Asia are driving market growth in this region

Glycomics Market Worth USD 2.0 Billion : Key Industry Insights, Current And Future Perspectives

 Major Growth Boosters:

The growth of this market is majorly driven by the increasing research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, growth in the proteomics market. On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment.

Expected Revenue Growth:

[173 Pages Report] The global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%.

What This Report Will Provide?

This study involved four major activities in estimating the current size of the glycomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525

The demand for glycomics products for drug discovery & development is estimated to grow at a high rate during the forecast period

Based on application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications. Drug discovery & development is the largest and the fastest-growing application segment in the market, majorly due to the increasing R&D investments in pharmaceutical and biotechnology companies and the growing number of drug discovery research activities in academic research institutes.

Developments:

• In June 2019, Agilent Technologies (US) has launched InfinityLab LC/MSD iQ System
• In June 2018, Thermo Fisher Scientific (US) had launched UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer.

Key Questions Addressed in The Report:

• Where will all these developments take the industry in the mid-to-long term?
• What are the recent trends affecting the glycomics market?
• Who are the key players in the market, and how intense is the competition?
• What are the key applications of glycomics?
• Which region is lucrative for the market?

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525

Regional Growth Analysis:

The global glycomics market is segmented into North America (US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa). In 2020, North America is expected to dominate the global market, followed by Europe. The largest share of North America is mainly attributed to increasing investments in glycomics research, rising R&D investments in pharmaceutical companies for drug discovery and the presence of all key players.

Women’s Health Diagnostics Market : Key Industry Insights, Current And Future Perspectives

 COVID-19 Impact on Global Women’s Health Diagnostics Market :

Since the beginning of 2020, more and more countries across the globe shut down their borders and limited transportation and travel to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation. This had disrupted the supply chains for the women’s health diagnostics market, temporarily leading to fall in demand due to uncertainty in the global economy and capital markets.

Expected Revenue Growth:

The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period.

What This Report Will Provide?

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Diagnostic tests such as POC tests are commonly used to detect HIV among patients. A rapid POC HIV test enables physicians to provide results and the HIV status of patients during the same visit. It does not require pre-test and post-test counseling of patients, as is common during traditional laboratory analysis.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901 

Recent Developments

• In 2021, F. Hoffmann-La Roche Ltd. Launched the uPath HER2 (4B5) Image Analysis and uPath Dual ISH Image Analysis.
• In 2021, Hologic, Inc. acquired Biotheranostics, a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, to strengthen its presence in the women’s health diagnostics market.
• In 2020, Hologic, Inc. launched the 3DQuorum Imaging Technology in Europe.
• In 2019, Carestream Health, Inc. opened a new global business operations center in Mumbai, India, expanding its market presence.

Frequently Asked Questions (FAQs) :

• Which are the top industry players in the global women’s health diagnostics market?
• Which global women’s health diagnostics appications have been included in this report?
• Which geographical region is dominating in the global women’s health diagnostics market?
• Which is the leading global women’s health diagnostics end user segment?

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=128928901 

Major Growth Boosters:

The market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.

The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period.

Regional Growth Analysis:

In 2019, North America accounted for the largest share of the women’s health diagnostics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing prevalence of cancer among women, the growing focus of manufacturers of women’s health diagnostic products on expanding their presence in this region, and the increasing demand for fertility testing monitors.

Women’s Health Diagnostics Market : Key Industry Insights, Current And Future Perspectives

 COVID-19 Impact on Global Women’s Health Diagnostics Market :

Since the beginning of 2020, more and more countries across the globe shut down their borders and limited transportation and travel to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation. This had disrupted the supply chains for the women’s health diagnostics market, temporarily leading to fall in demand due to uncertainty in the global economy and capital markets.

Expected Revenue Growth:

The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period.

What This Report Will Provide?

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Diagnostic tests such as POC tests are commonly used to detect HIV among patients. A rapid POC HIV test enables physicians to provide results and the HIV status of patients during the same visit. It does not require pre-test and post-test counseling of patients, as is common during traditional laboratory analysis.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901 

Recent Developments

• In 2021, F. Hoffmann-La Roche Ltd. Launched the uPath HER2 (4B5) Image Analysis and uPath Dual ISH Image Analysis.
• In 2021, Hologic, Inc. acquired Biotheranostics, a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, to strengthen its presence in the women’s health diagnostics market.
• In 2020, Hologic, Inc. launched the 3DQuorum Imaging Technology in Europe.
• In 2019, Carestream Health, Inc. opened a new global business operations center in Mumbai, India, expanding its market presence.

Frequently Asked Questions (FAQs) :

• Which are the top industry players in the global women’s health diagnostics market?
• Which global women’s health diagnostics appications have been included in this report?
• Which geographical region is dominating in the global women’s health diagnostics market?
• Which is the leading global women’s health diagnostics end user segment?

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=128928901 

Major Growth Boosters:

The market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.

The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period.

Regional Growth Analysis:

In 2019, North America accounted for the largest share of the women’s health diagnostics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing prevalence of cancer among women, the growing focus of manufacturers of women’s health diagnostic products on expanding their presence in this region, and the increasing demand for fertility testing monitors.

Laboratory Filtration Market : Growing Demand For Membrane Filtration Technology

 The study involved four major activities in estimating the current size of the laboratory filtration market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizes with industry experts across the value chain through primary research. 

Growth in this market is driven majorly by the rising R&D spending in the pharmaceutical & biopharmaceutical industry, growing demand for membrane filtration technology, increasing purity requirements in end-user segments, and growing focus on developing large-molecule biopharmaceuticals. However, the high cost of systems is expected to restrain the growth of the lab filtration market to a certain extent during the forecast period.

What the Market Looks Like?

The global laboratory filtration market size is projected to reach USD 4.1 billion by 2025 from USD 2.5 billion in 2019, at a CAGR of 8.3% during the forecast period. The global lab filtration market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.

Based on product, the market is segmented into filtration media (filter papers, membrane filters, syringe and syringeless filters, filtration microplates, and other filtration media), filtration assemblies (microfiltration assemblies, reverse osmosis assemblies, ultrafiltration assemblies, vacuum filtration assemblies, and other filtration assemblies), and filtration accessories (filter holders, filter funnels, filter flasks, membrane dispensers, filter housings, cartridges, vacuum pumps, seals, and other filtration accessories).

Based on technique, the market is segmented into microfiltration, ultrafiltration, reverse osmosis, vacuum filtration, and nanofiltration. The microfiltration segment accounted for the largest share in 2018, while the ultrafiltration segment is projected to witness the highest growth during the forecast period. Rising R&D activities in the pharma industry and wide applications in the food & beverage industry are the key factors boosting the growth of this market segment. Also, the growing production of biotherapeutic molecules is expected to drive the demand for ultrafiltration filters in the coming years.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12936082

What are Key Trends in the Market? 

The growth of the Laboratory Filtration Market is primarily influenced by the following factors:

• Rising R&D Spending in the Pharmaceutical & Biopharmaceutical Industry
• Growing Demand for Membrane Filtration Technology
• Increasing Purity Requirements in End-User Segments
• Focus on Developing Large-Molecule Biopharmaceuticals

Based on end user, the market is segmented into pharmaceutical & biotechnology companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutions. The pharmaceutical & biotechnology companies segment accounted for the largest market share in 2018.

Read more about Laboratory Filtration Market @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=12936082

Key Questions Addressed in the Report

• Which are the top 10 players operating in the lab filtration market?
• What are the drivers, restraints, opportunities, and challenges of the market?
• What are the prevailing industry trends, and what is the current scenario in the market?
• What are the growth trends in the market at the segmental and overall levels?
• How is the Lab filtration market performing in different regions across the globe?

Inspection Machines Market Worth USD 871 Million : Growth In The Medical Devices Industry

 Major Growth Boosters :

The growth of this market is majorly driven as companies are now increasingly adopting inspection systems throughout their production lines due to the growing concerns to the regulatory mandates introduced by the government and regulatory bodies in the healthcare industry to maintain compliance with Good Manufacturing Practices (GMP).

Expected Revenue Growth:

The Inspection machines market is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4% during the forecast period.

What This Report Will Provide?

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085

COVID-19 Impact on the Inspection Machines Market

Since the beginning of 2020, the majority of the countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation. This had disrupted the supply chains for the inspection machines market, temporarily leading to a fall in demand due to uncertainty in the global economy and capital markets.

Recent Developments :

• In 2020, Antares partnered with IMA; a company engaged in the design & production of machines for process automation and packaging of pharmaceutical & cosmetic products.
• In 2019, METTLER-TOLEDO International Inc. launched their Tablet-Pro metal detection systems.
• In 2019, Cognex Corporation launched the DSMax32T laser displacement 3D system.
• In 2019, ACG Inspection opened a new Centre of Excellence in Switzerland.

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=81453085  

Growing number of regulatory mandates to maintain compliance with GMP in the healthcare industry

Regulatory agencies, such as the Food and Drug Administration (US), European Medicines Agency, and the Pharmaceuticals and Medical Devices Agency (Japan), ensure the quality of drugs and medical devices by carefully monitoring the compliance of manufacturers with Current Good Manufacturing Practice (CGMP) regulations. CGMP regulations for drugs and medical devices contain minimum requirements for the methods, facilities, and controls used in manufacturing, processing, and packing them. The regulations that have been implemented ensure that products are safe for use and have the ingredients and strength they claim to have.

Regional Growth Analysis:

In 2019, North America accounted for the largest share of the inspection machines market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the significant growth opportunities for players operating in the inspection machines market owing to the presence of a large number of pharmaceutical and biotechnology companies & medical device manufacturers in the region, stringent regulatory mandates for healthcare manufacturers, an increasing number of inspection checkpoints in the production line, and highly regulated inspection standards & obligatory compliance in the region.